glp 1 injections The Latest on GLP-1s | Lexington Medical Center Blog New Biweekly GLP-1 Shot Lowers

Off-Label Use: When a medication FDA-approved for one condition (like diabetes) is prescribed for a different condition (like weight loss)

Online platforms list Wegovy at 9,500 for a four-week supply , but the authenticity is questionable

Clin Obes 11, e12432 (2021)

Postpartum weight retention that resolves gradually with lifestyle changes may not warrant medication

health insurance landscape creates both the opportunity and the constraint: commercial insurance covering GLP-1 for diabetes generates large, well-reimbursed prescription volumes, but coverage for obesity indications varies widely, with Medicare explicitly prohibited from covering weight loss drugs until the Treat and Reduce Obesity Act passes a legislative gap that excludes tens of millions of Medicare beneficiaries from covered GLP-1 obesity access

Should be paired with healthy diet and exercise